Value of FDG PET/CT in Patient Management and Outcome of Skeletal and Soft Tissue Sarcomas.
Publication
, Journal Article
Sheikhbahaei, S; Marcus, C; Hafezi-Nejad, N; Taghipour, M; Subramaniam, RM
Published in: PET Clin
July 2015
Fluorodeoxyglucose (FDG)-PET/computed tomography (CT) has been increasingly used in bone and soft tissue sarcomas and provides advantages in the initial tumor staging, tumor grading, therapy assessment, and recurrence detection. FDG-PET/CT metabolic parameters are reliable predictors of survival in sarcomas and could be implemented in risk stratification models along with other prognostic factors in these patients.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
PET Clin
DOI
EISSN
1879-9809
Publication Date
July 2015
Volume
10
Issue
3
Start / End Page
375 / 393
Location
United States
Related Subject Headings
- Tomography, X-Ray Computed
- Soft Tissue Neoplasms
- Sarcoma
- Radiopharmaceuticals
- Prognosis
- Positron-Emission Tomography
- Nuclear Medicine & Medical Imaging
- Neoplasm Staging
- Multimodal Imaging
- Male
Citation
APA
Chicago
ICMJE
MLA
NLM
Sheikhbahaei, S., Marcus, C., Hafezi-Nejad, N., Taghipour, M., & Subramaniam, R. M. (2015). Value of FDG PET/CT in Patient Management and Outcome of Skeletal and Soft Tissue Sarcomas. PET Clin, 10(3), 375–393. https://doi.org/10.1016/j.cpet.2015.03.003
Sheikhbahaei, Sara, Charles Marcus, Nima Hafezi-Nejad, Mehdi Taghipour, and Rathan M. Subramaniam. “Value of FDG PET/CT in Patient Management and Outcome of Skeletal and Soft Tissue Sarcomas.” PET Clin 10, no. 3 (July 2015): 375–93. https://doi.org/10.1016/j.cpet.2015.03.003.
Sheikhbahaei S, Marcus C, Hafezi-Nejad N, Taghipour M, Subramaniam RM. Value of FDG PET/CT in Patient Management and Outcome of Skeletal and Soft Tissue Sarcomas. PET Clin. 2015 Jul;10(3):375–93.
Sheikhbahaei, Sara, et al. “Value of FDG PET/CT in Patient Management and Outcome of Skeletal and Soft Tissue Sarcomas.” PET Clin, vol. 10, no. 3, July 2015, pp. 375–93. Pubmed, doi:10.1016/j.cpet.2015.03.003.
Sheikhbahaei S, Marcus C, Hafezi-Nejad N, Taghipour M, Subramaniam RM. Value of FDG PET/CT in Patient Management and Outcome of Skeletal and Soft Tissue Sarcomas. PET Clin. 2015 Jul;10(3):375–393.
Published In
PET Clin
DOI
EISSN
1879-9809
Publication Date
July 2015
Volume
10
Issue
3
Start / End Page
375 / 393
Location
United States
Related Subject Headings
- Tomography, X-Ray Computed
- Soft Tissue Neoplasms
- Sarcoma
- Radiopharmaceuticals
- Prognosis
- Positron-Emission Tomography
- Nuclear Medicine & Medical Imaging
- Neoplasm Staging
- Multimodal Imaging
- Male